Safety and Efficacy of NovaTears® + Omega-3 (0.2%) Eye Drops on Signs and Symptoms of Dry Eye

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

November 9, 2020

Primary Completion Date

February 17, 2021

Study Completion Date

February 17, 2021

Conditions

Evaporative Dry Eye Disease

Interventions

DEVICE

NovaTears® + Omega-3 (Perfluorohexyloctane with 0.2% w/w Omega-3 fatty acid ethyl esters)

Eye drops

Trial Locations (2)

NTO-001 Investigational Site, Heidelberg

NTO-001 Investigational Site, Nuremberg